Of the 50 instances in which we found repeating ANA tests was reasonable, 42% (count 21 repeated ANA tests) were due to laboratory-related issues, while 38% (count 19) were due to new symptoms that could be related to a yet-to-be-diagnosed connective tissue disease. Here, BTG3 is linked to connective tissue disorder.